← 返回专利悬崖列表
CAS 107-19-7
prop-2-yn-1-ol3-Hydroxy-1-propyne
登记编号：RIBO-004、(II)101438-75-a、(IX)169995-1-a、(X)169995-4-a、(VII)169995-8-a、DARU-002、CINA-002
应用背景（按来源药适应症）
乳腺癌琥珀酸瑞波西利乳腺癌Paclitaxel/Encequidar mesylate腺癌Paclitaxel/Encequidar mesylate血管肉瘤Paclitaxel/Encequidar mesylate实体瘤Paclitaxel/Encequidar mesylate避孕屈螺酮口腔炎，口疮屈螺酮经前焦虑性障碍屈螺酮经前期综合征屈螺酮痛经屈螺酮抑郁屈螺酮HIV感染乙醇达芦那韦/利托那韦HIV感染乙醇达芦那韦/考比司他HIV感染乙醇达芦那韦胰腺癌紫杉醇非小细胞肺癌紫杉醇霍奇金病紫杉醇精原细胞瘤紫杉醇卵巢癌紫杉醇乳腺癌紫杉醇高钙血症盐酸西那卡塞继发性甲状旁腺功能亢进症盐酸西那卡塞甲状旁腺功能亢进症盐酸西那卡塞原发性甲状旁腺功能亢进症盐酸西那卡塞慢性肾功能不全盐酸西那卡塞心源性水肿盐酸西那卡塞
来源药（使用该中间体的合成路线）
| 品种 | 梯队 | 到期年 |
|---|---|---|
| 琥珀酸瑞波西利Ribociclib Succinate | Tier A · 立即攻坚 | 2029 |
| Paclitaxel/Encequidar mesylate | Tier C · 观察 / 贸易 | - |
| 屈螺酮Drospirenone | Tier C · 观察 / 贸易 | - |
| 乙醇达芦那韦/利托那韦Darunavir Ethanolate/Ritonavir | Tier C · 观察 / 贸易 | - |
| 乙醇达芦那韦/考比司他Darunavir Ethanolate/Cobicistat | Tier C · 观察 / 贸易 | - |
| 乙醇达芦那韦Darunavir Ethanolate | Tier B · 提前布局 | - |
| 紫杉醇Paclitaxel | Tier B · 提前布局 | - |
| 盐酸西那卡塞Cinacalcet Hydrochloride | Tier B · 提前布局 | - |
合成路线中的位置（上下游链）
按路线登记顺序排列，左→右为合成方向；高亮为当前 CAS，其余可点击跳转对应档案。
5-bromo-2,4-dichloropyrimidine→cyclopentanamine→5-bromo-2-chloro-N-cyclopentylpyrimidin-4-amine→prop-2-yn-1-ol→3-(2-chloro-4-(cyclopentylamino)pyrimidin-5-yl)prop-2-yn-1-ol→(2-chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)methanol→dimethylamine→2-chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide→tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate→tert-butyl 4-(6-((7-cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate→5-chloro-2-nitropyridine→piperazine→1-(6-nitropyridin-3-yl)piperazine→tert-butyl 4-(6-nitropyridin-3-yl)piperazine-1-carboxylate
3,3,7,7,9-Pentamethyl-1,5-dioxaspiro[5.5]undec-8-en-8-yl trifluoromethanesulfonate→3-Hydroxy-1-propyne→3-(3,3,7,7,9-Pentamethyl-1,5-dioxaspiro[5.5]undec-8-en-8-yl)prop-2-yn-1-ol→3-[(1Z)-3-Hydroxyprop-1-en-1-yl]-2,2,4-trimethylcyclohex-3-en-1-one→(R*)-[(1R*)-3-(Z)-[3-[[tert-Butyl(dimethyl)silyl]oxy]prop-1-en-1-yl]-2,2,4-trimethyl-1-[(trimethylsilyl)oxy]cyclohex-3-en-1-yl](6-ethenyl-6-methylcyclohex-1-en-1-yl)methanol→3-[(1Z)-3-[[tert-Butyl(dimethyl)silyl]oxy]prop-1-en-1-yl]-2,2,4-trimethylcyclohex-3-en-1-one→3-[(1Z)-3-[[tert-Butyl(dimethyl)silyl]oxy]prop-1-en-1-yl]-2,2,4-trimethyl-1-[(trimethylsilyl)oxy]cyclohex-3-ene-1-carbonitrile→3-[(1Z)-3-[[tert-Butyl(dimethyl)silyl]oxy]prop-1-en-1-yl]-2,2,4-trimethyl-1-[(trimethylsilyl)oxy]cyclohex-3-ene-1-carbaldehyde→N'-(2-Ethenyl-2-methylcyclohexylidene)-2,4,6-tri(propan-2-yl)benzene-1-sulfonohydrazide→(1S*)-1-[(S*)-(6-Ethenyl-6-methylcyclohex-1-en-1-yl)(hydroxy)methyl]-3-[3-hydroxyprop-1-en-1-yl]-2,2,4-trimethylcyclohex-3-en-1-ol→3-[(4S*,5S*)-4-(6-Ethenyl-6-methylcyclohex-1-en-1-yl)-6,6,8-trimethyl-2-oxo-1,3-dioxaspiro[4.5]dec-7-en-7-yl]prop-2-en-1-yl 1H-imidazole-1-carboxylate→(4S*,5S*)-4-(6-Ethenyl-6-methylcyclohex-1-en-1-yl)-7-[3-hydroxyprop-1-en-1-yl]-6,6,8-trimethyl-1,3-dioxaspiro[4.5]dec-7-en-2-one→(4S*,5S*)-4-(6-Ethenyl-6-methylcyclohex-1-en-1-yl)-6,6,8-trimethyl-7-[(1E)-3-[(prop-2-en-1-yl)oxy]prop-1-en-1-yl]-1,3-dioxaspiro[4.5]dec-7-en-2-one
(2S,4aR,4bS,6aS,7aS,8aS,8bR,8cR)-2-Hydroxy-4a,6a-dimethyl-2,3,4,4a,4b,5,6,6a,7a,8,8a,8b,8c,9-tetradecahydrocyclopropa[4,5]cyclopenta[1,2-a]phenanthren-7(1H)-one→(2S,4aR,4bS,6aS,7aS,8aS,8bS,8cR,9R)-2,9-Dihydroxy-4a,6a-dimethyl-2,3,4,4a,4b,5,6,6a,7a,8,8a,8b,8c,9-tetradecahydrocyclopropa[4,5]cyclopenta[1,2-a]phenanthren-7(1H)-one→(2S,4aR,4bS,6aS,7aS,8aS,8bS,8cR,9R)-9-Hydroxy-4a,6a-dimethyl-7-oxo-1,2,3,4,4a,4b,5,6,6a,7,7a,8,8a,8b,8c,9-hexadecahydrocyclopropa[4,5]cyclopenta[1,2-a]phenanthren-2-yl 2,2-dimethylpropanoate→(1aS,3S,5aR,5bS,7aS,8aS,9aS,9bS,9cR,10R,10aR)-10-Hydroxy-5a,7a-dimethyl-8-oxohexadecahydro-2H-cyclopropa[4',5']cyclopenta[1',2':1,2]phenanthro[8a,9-b]oxiren-3-yl 2,2-dimethylpropanoate→(1aS,3S,5aR,5bS,7aS,8aS,9aS,9bS,9cR,10S,10aS)-10-Chloro-5a,7a-dimethyl-8-oxohexadecahydro-2H-cyclopropa[4',5']cyclopenta[1',2':1,2]phenanthro[8a,9-b]oxiren-3-yl 2,2-dimethylpropanoate→(2S,4aR,4bS,6aS,7aS,8aS,8bS,8cR,10aR)-10a-Hydroxy-4a,6a-dimethyl-7-oxo-1,2,3,4,4a,4b,5,6,6a,7,7a,8,8a,8b,8c,10a-hexadecahydrocyclopropa[4,5]cyclopenta[1,2-a]phenanthren-2-yl 2,2-dimethylpropanoate→(2S,4aR,4bS,6aS,7aS,8aS,8bS,8cR,10aR)-2,10a-Dihydroxy-4a,6a-dimethyl-2,3,4,4a,4b,5,6,6a,7a,8,8a,8b,8c,10a-tetradecahydrocyclopropa[4,5]cyclopenta[1,2-a]phenanthren-7(1H)-one→(1aR,1bR,3S,5aR,5bS,7aS,8aS,9aS,9bS,9cR,9dR)-1b,3-Dihydroxy-5a,7a-dimethylperhydrocyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthren-8-one→3-Hydroxy-1-propyne→(1aR,1bR,3S,5aR,5bS,7aS,8S,8aS,9aS,9bS,9cR,9dR)-8-(3-Hydroxyprop-1-yn-1-yl)-5a,7a-dimethyloctadecahydro-1bH-cyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthrene-1b,3,8-triol→(1aR,1bR,3S,5aR,5bS,7aS,8S,8aS,9aS,9bS,9cR,9dR)-8-(3-Hydroxypropyl)-5a,7a-dimethyloctadecahydro-1bH-cyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthrene-1b,3,8-triol→(1R,2R,4R,5R,10R,11S,14S,15S,16S,18S,19S)-5-Hydroxy-10,14-dimethylspiro[hexacyclo[9.8.0.0(2,4).0(5,10).0(14,19).0(16,18)]nonadecane-15,2'-oxolane]-5',7-dione→1-Bromanyl-3-methoxy-propane→(3-Methoxypropyl)lithium→(1aR,1bR,3S,5aR,5bS,7aS,8S,8aS,9aS,9bS,9cR,9dR)-8-(3-Methoxypropyl)-5a,7a-dimethyloctadecahydro-1bH-cyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthrene-1b,3,8-triol
(2S,4aR,4bS,6aS,7aS,8aS,8bR,8cR)-2-Hydroxy-4a,6a-dimethyl-2,3,4,4a,4b,5,6,6a,7a,8,8a,8b,8c,9-tetradecahydrocyclopropa[4,5]cyclopenta[1,2-a]phenanthren-7(1H)-one→(3S,5S,7S,11R,14S)-7,11-dimethyl-6-oxopentacyclo[8.8.0.0(2,7).0(3,5).0(11,16)]octadec-16-en-14-yl acetate→(2S,4aR,4bS,6aS,7aS,8aS,8bS,8cR,9R)-2,9-Dihydroxy-4a,6a-dimethyl-2,3,4,4a,4b,5,6,6a,7a,8,8a,8b,8c,9-tetradecahydrocyclopropa[4,5]cyclopenta[1,2-a]phenanthren-7(1H)-one→(3S,5S,7S,11R,14S,18R)-14-[(tert-butyldimethylsilyl)oxy]-18-hydroxy-7,11-dimethylpentacyclo[8.8.0.0(2,7).0(3,5).0(11,16)]octadec-16-en-6-one→(2R,5S,7S,9R,10R,13S,15S,17S)-5-[(tert-butyldimethylsilyl)oxy]-10-hydroxy-2,17-dimethyl-8-oxahexacyclo[9.8.0.0(2,7).0(7,9).0(12,17).0(13,15)]nonadecan-16-one→(1aS,3S,5aR,5bS,7aS,8aS,9aS,9bS,9cR,10S,10aS)-10-Chloro-5a,7a-dimethyl-8-oxohexadecahydro-2H-cyclopropa[4',5']cyclopenta[1',2':1,2]phenanthro[8a,9-b]oxiren-3-yl 2,2-dimethylpropanoate→(2R,5S,7S,9S,10S,13S,15S,17S)-10-chloro-5-hydroxy-2,17-dimethyl-8-oxahexacyclo[9.8.0.0(2,7).0(7,9).0(12,17).0(13,15)]nonadecan-16-one→(2S,4aR,4bS,6aS,7aS,8aS,8bS,8cR,10aR)-2,10a-Dihydroxy-4a,6a-dimethyl-2,3,4,4a,4b,5,6,6a,7a,8,8a,8b,8c,10a-tetradecahydrocyclopropa[4,5]cyclopenta[1,2-a]phenanthren-7(1H)-one→(1aR,1bR,3S,5aR,5bS,7aS,8aS,9aS,9bS,9cR,9dR)-1b,3-Dihydroxy-5a,7a-dimethylperhydrocyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthren-8-one→3-Hydroxy-1-propyne→(1aR,1bR,3S,5aR,5bS,7aS,8S,8aS,9aS,9bS,9cR,9dR)-8-(3-Hydroxyprop-1-yn-1-yl)-5a,7a-dimethyloctadecahydro-1bH-cyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthrene-1b,3,8-triol→(1aR,1bR,3S,5aR,5bS,7aS,8S,8aS,9aS,9bS,9cR,9dR)-8-(3-Hydroxypropyl)-5a,7a-dimethyloctadecahydro-1bH-cyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthrene-1b,3,8-triol→(1R,2R,4R,5R,10R,11S,14S,15S,16S,18S,19S)-5-Hydroxy-10,14-dimethylspiro[hexacyclo[9.8.0.0(2,4).0(5,10).0(14,19).0(16,18)]nonadecane-15,2'-oxolane]-5',7-dione
1-[2(R)-(2,4-Difluorophenyl)-2-hydroxy-1(R)-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-3-[4-(1H-tetrazol-1-yl)phenyl]imidazolidin-2-one→(2R,5S,7S,9R,10R,13S,15S,17S)-10-(methanesulfonyloxy)-2,17-dimethyl-16-oxo-8-oxahexacyclo[9.8.0.0(2,7).0(7,9).0(12,17).0(13,15)]nonadecan-5-yl 2,2-dimethylpropanoate→(2R,5S,7S,9S,10S,13S,15S,17S)-10-bromo-2,17-dimethyl-16-oxo-8-oxahexacyclo[9.8.0.0(2,7).0(7,9).0(12,17).0(13,15)]nonadecan-5-yl 2,2-dimethylpropanoate→(2S,4aR,4bS,6aS,7aS,8aS,8bS,8cR,10aR)-10a-Hydroxy-4a,6a-dimethyl-7-oxo-1,2,3,4,4a,4b,5,6,6a,7,7a,8,8a,8b,8c,10a-hexadecahydrocyclopropa[4,5]cyclopenta[1,2-a]phenanthren-2-yl 2,2-dimethylpropanoate→(2S,4aR,4bS,6aS,7aS,8aS,8bS,8cR,10aR)-2,10a-Dihydroxy-4a,6a-dimethyl-2,3,4,4a,4b,5,6,6a,7a,8,8a,8b,8c,10a-tetradecahydrocyclopropa[4,5]cyclopenta[1,2-a]phenanthren-7(1H)-one→(1aR,1bR,3S,5aR,5bS,7aS,8aS,9aS,9bS,9cR,9dR)-1b,3-Dihydroxy-5a,7a-dimethylperhydrocyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthren-8-one→3-Hydroxy-1-propyne→(1aR,1bR,3S,5aR,5bS,7aS,8S,8aS,9aS,9bS,9cR,9dR)-8-(3-Hydroxyprop-1-yn-1-yl)-5a,7a-dimethyloctadecahydro-1bH-cyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthrene-1b,3,8-triol→(1aR,1bR,3S,5aR,5bS,7aS,8S,8aS,9aS,9bS,9cR,9dR)-8-(3-Hydroxypropyl)-5a,7a-dimethyloctadecahydro-1bH-cyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthrene-1b,3,8-triol
本站可供应的对应中间体
同 CAS 多家在售供应横向对比；价格区间为供应方挂牌口径，实价以询价确认为准。
| 供应商 | 产品 | 价格区间 | 最小起订 | 货期 | 资质 | 操作 |
|---|---|---|---|---|---|---|
| Unibest Nantong cGMP Site | 2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic
acid Pharmaceutical Intermediates | 询价 | 询价 | 询价 | — | |
| Unibest Taizhou GMP-like Site | 2-Chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6- carboxamide Pharmaceutical Intermediates | 询价 | 询价 | 询价 | — |
本页为中间体 CAS 注册档案：同 CAS 的多条路线登记已合并；后续供应商报价与买方需求以该 CAS 为主键撮合。